Research Management and Impact Tool (ReMIT)
About
Sign-in / Sign-up
Open menu
David
OCB
Studies
Status: Concept
What is the immunogenicity and safety of MVA-BN vaccine for the prevention of mpox in adults living with HIV with different level of CD4 counts (<200 cells/µL; 200 to 499 cells/µL; ≥ 500 cells/µL).
Study details:
Other
in
Congo (Democratic Republic of the)
Principal investigator:
david
Latest update:
Study created | 23rd December 2024
Modal title
About
Sign-in / Sign-up
Admin panel
MSF science portal
About this site
